Minerva Surgical, Inc.
UTRS · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -10.6% | 6.8% | -9.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 52% | 55.3% | 56% | 53.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -38.1% | -41.3% | -81.7% | -37.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -60% | -64.8% | -107.3% | -45.2% |
| EPS Diluted | -0.81 | -0.98 | -2.81 | -2.01 |
| % Growth | 17.3% | 65.1% | -39.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |